SPRING1 and hepatocellular carcinoma: Moreover, the suppression of cell death and the reductions of lipid ROS and Fe2+ levels attributed to C12ORF49 overexpression were significantly reversed by treatment with RSL3 (a ferroptosis inducer) (Fig. 5D–F), further supporting the fact that C12ORF49 promotes HCC cell survival by inhibiting ferroptosis.